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Objective: To evaluate the systemic inﬂammatory response in preeclampsia compared to normal
pregnancy.
Materials and methods: The following serum parameters were determined in three groups of patients:
leukocytes, neutrophils, tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), C-reactive protein (CRP),
and certain markers of oxidative stress. Fetal status was assessed based on the gestational age at which
birth occurred, on the Apgar score, and on fetal weight.
Results: In preeclampsia, a higher systemic inﬂammatory status was found compared to normal preg-
nancy. Gestational age at birth, fetal weight, and Apgar score were signiﬁcantly lower in the group with
preeclampsia compared to normal pregnancy.
Conclusion: In preeclampsia, there is an increased systemic inﬂammatory response compared to normal
pregnancy, which can inﬂuence fetal status at birth.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Preeclampsia (PE) is a severe complication of pregnancy, having
a global incidence of 2e10%, and is one of the main causes of
maternalefetal morbidity and mortality [1,2]. In spite of performed
researches, the pathogenesis of PE is not completely understood.
Recent evidence suggests the implication in the pathogenesis of this
disease of an excessive systemic inﬂammatory response during
pregnancy, with the activation of immune and acquired systems [3].
Two different theories have been developed: the ischemic vascular
origin and the abnormal immune response [4]. A current hypothesis
uniﬁes these two concepts; according to this, an altered immune
response induces an abnormal early placental function in preg-
nancy, with syncytiotrophoblast ischemia and the formation of
products that extensively damage endothelial integrity [5]. How-
ever, the mechanisms by which the immune response can activate
the processes of this cascade are not known, but they are considered
to act synergistically with other additional factors, such as predis-
posing maternal factors and environmental factors [6]. An989 Boulevard, 400094, Cluj-
lutan).
bstetrics & Gynecology. Publishedimportant characteristic of systemic inﬂammation in PE is the
absence of Th2 skewness that is characteristic of normal pregnancy
and, thus, the predominance of Th1 type immunity [3,7]. It has been
hypothesized that endothelial dysfunction in PE is part of a gener-
alized intravascular inﬂammatory reaction involving intravascular
leukocytes as well as the clotting and complement system, which
can be considered as the extreme end of the range of maternal
adaptations to pregnancy [8]. Clinical and biochemical evidence
suggests that the disturbance of normal endothelial cell function
may be a primary cause in the pathogenesis of PE [9]. Endothelial
dysfunction is accompanied by elevated levels of inﬂammatory
markers [9]. It has been hypothesized that placental hypoxia,
resulting from utero-placental arterial insufﬁciency, ampliﬁes the
release of inﬂammatory stimuli into the maternal circulation,
involving lipid peroxidation, leukocyte activation, and stimulation
of proinﬂammatory cytokine production by the placenta [8].
This study aimed to evaluate the systemic inﬂammatory
response in PE compared to normal pregnancy. The severity of the
preeclamptic syndrome as well as fetal status at birth was assessed
based on the markers of the inﬂammatory syndrome. At the same
time, it attempted to demonstrate possible correlations between
systemic inﬂammatory response in PE, the severity of this disorder,
and fetal status at birth.by Elsevier Taiwan LLC. All rights reserved.
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Study design
A prospective transversal study was performed during the
period November 1, 2010 to July 1, 2011 in “Dominic Stanca” Clinic
of Obstetrics and Gynecology, Cluj-Napoca, Romania. Three groups
were investigated: a normal pregnancy group (NP), a preeclampsia
group (PE), and a nonpregnant control group (C). The study
included patients aged between 20 years and 40 years. The NP and
PE groups included patients with singleton pregnancies, with
gestational ages between 28 weeks and 41 weeks of amenorrhea
(WA). The PE group included patients with the moderate or severe
form of preeclampsia. Preeclampsia was deﬁned according to the
criteria of the International Society for the Study of Hypertension in
Pregnancy (ISSHP): systolic and diastolic blood pressures above
140 mmHg and 90 mmHg, respectively, on at least two consecutive
measurements at least 6 hours apart, occurring after the 20th week
of gestation. The rise in blood pressure was accompanied by pro-
teinuria (>300 mg/L, in a 24-hour urine collection) and/or edema
prior to commencing medication. Blood pressure was measured in
a sitting position with a sphygmomanometer. Diastolic blood
pressure was recorded at Phase IV Korotkoff sound. Preeclampsia
was considered to be moderate in cases with blood pressure values
from 140/90 mmHg to 160/110 mmHg and severe in cases with
blood pressure values >160/110 mm Hg, and proteinuria >5 g/
24 hours, as well as pulmonary edema, seizures, oliguria, throm-
bocytopenia, abnormal liver enzymes, or persistent severe central
nervous system symptoms (blindness, blurred vision, headaches).
The patients included in the NP and C groups had blood pressure
(BP) values within normal limits. BP was considered normal when
systolic blood pressure (SBP) values were 135 mmHg, and dia-
stolic blood pressure (DBP) values were <85 mmHg. Pregnant
women in labor or with ruptured membranes were excluded from
the PE and NP groups. Women with clinically manifest infections,
disorders associated with chronic systemic inﬂammatory response,
a recent history (within 14 days) of nonsteroidal anti-inﬂammatory
or corticosteroid treatment were excluded from all three groups. All
patients were included in the study groups if they met the
mentioned inclusion and exclusion criteria, after signing an
informed consent for their participation in the study. The studywas
approved by “Iuliu Hat¸ieganu” University of Medicine and the
Pharmacy Ethics Committee.Measurements
BPwasmeasured with the patients in a sitting position, with the
arm at the same level as the heart. For patients included in the NPTable 1
Biochemical parameters, measurement units, normal values, and measurement techniqu
Parameter Measurement unit Normal values Me
Leukocytes /mL 3800e10,000 Mu
anNeutrophils /mL 2000e7000
Tumor necrosis factor-a (TNF-a) pg/mL 4.5 ± 2.1 Hu
Interleukin 6 (IL-6) pg/mL 0.9 ± 0.3 Hu
C-reactive protein (CRP) ng/mL 750 ± 250 Hu
Lipid peroxides nmol/mL 1.8 ± 0.1 De
str
Carbonylated proteins nmol/mg protein 1.2 ± 0.025 Re
of
Ceruloplasmin ng/100 mL 28 ± 4 Ra
Hydrogen donor capacity Inhibition (%) 39 ± 1 Re
an
Nitrite and nitrate mmol/L 12.5 ± 0.5 Reand PE groups, fetal status at birth was evaluated based on the
gestational age at which birth occurred, on the Apgar score, and on
birth weight (normal values between 2500 g and 4000 g). In
addition, for these groups of patients, the type of delivery (vaginal
or cesarean section) was recorded.
Five milliliters of venous blood were harvested from each pa-
tient before breakfast; it centrifuge speedwas 1000X and the serum
obtained was stored at70C for future determinations. For NP and
PE groups, blood was taken between 28 weeks and 41 weeks of
gestation.
The serum parameters shown in Table 1 were measured in the
patients of all three study groups.
Statistical analysis
Quantitative variables were summarized as mean and standard
deviation (expressed as mean ± standard deviation) whenever data
was normally distributed; otherwise the median and percentiles
(25% and 75% percentiles) were reported. The Kolmogor-
oveSmirnov test was used to assess the distribution of data. The
comparisons of metric variables between the groups were con-
ducted with the analysis of variance test (for the comparison of >2
groups) or the t test (for the comparison of 2 groups) whenever
datawas normally distributed; otherwise theMann-Whitney U test
or the KruskalleWallis test for multiple groups was applied. The
correlations between quantitative parameters were explored with
the Pearson correlation coefﬁcient whenever data was normally
distributed; otherwise the Spearman's rho correlation coefﬁcient
was used.
Qualitative variables were summarized as percentages and
associated 95% conﬁdence intervals (CIs) at a signiﬁcance level of
5%, using an optimized formula [10]. The comparison between two
proportions was conducted using the Z test. Statistical parameters
such as sensitivity, speciﬁcity, positive and negative predictive
values, and associated 95% conﬁdence intervals computed using an
optimized formulawere calculated to characterize a new diagnostic
test. Statistical analyses were performed with SPSS software
version 16 (SPSS Inc., Chicago, IL, USA). All p values were two-tailed
and were considered signiﬁcant only when lower than 0.05.
Results
The study included 230 women, 80 in the PE group, 78 in the NP
group, and 72 in the C group. Women in the PE group had a mean
age of 30.43 ± 4.89 years [95% CI (29.34; 34.51)]; women in the NP
group had a mean age of 29.56 ± 4.28 years [95% CI (28.60; 30.53)],
and the median of the age of women in the C group was 32 years
(25% quartile ¼ 27 years and 75% quartile ¼ 37 years). Noes.
asurement technique
ltichannel automated hematology analyzer, sorting cells depending on their size
d electrical impedance e 319
man TNF-a Quantikine HS Elisa kit
man IL6 Quantikine HS Elisa kit
man C-Reactive Protein Quantikine Elisa kit
termination of the colored compound resulting from the peroxidation of lipid
uctures with 2-thiobarbituric acid
action with 2.4-dinitrophenylhydrazine, resulting in the formation
2.4-dinitrophenylhydrazone, which can be measured spectrophotometrically
vin method
duction of the stable radical 1.1-diphenylpicrylhydrazyl (DPPH) by nonenzymatic
tioxidant components: glutathione, tocopherol, ascorbic acid
action with the Griess reagent
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between the groups (KruskaleWallis statistics ¼ 5.768, p ¼ 0.06).Inﬂammatory syndrome
Summaries of the inﬂammatory syndrome parameters assessed
according to the criteria presented in the “Materials and methods”
section are shown in Table 2. The differences in the proportions of
women who met a certain criterion by pairs of groups were tested
and the results are presented in Table 2.
The pairs of groups were compared in order to identify statis-
tically signiﬁcant differences with respect to several criteria, using
the Z test for the comparison of two proportions. The results are
presented in Table 3.
The results of the comparison of serum inﬂammatory parame-
ters between the groups are presented in Table 4.
The summary of inﬂammatory parameters according to the
severity of preeclampsia is presented in Table 5.
Inﬂammatory markers can be used for evaluating the systemic
inﬂammatory response in PE. In this context, if two criteria are
considered simultaneously, tumor necrosis factor-a (TNF-
a) > 13.2 pg/mL and interleukin-6 (IL-6) > 2.4 pg/mL, all women in
the PE group meet these criteria, while none of the women in the
NP or the C group meet these criteria. The same is true if three
criteria are simultaneously considered, TNF-a > 13.2 pg/mL, IL-6 >
2.4 pg/mL, and C-reactive protein (CRP) > 2000 ng/mL, all women
in the PE groupmeet these criteria, while none of thewomen in the
NP or the C groupmeet these criteria. If we deﬁne the simultaneous
two-fold increase in TNF-a and IL-6 values compared to normal
values as a diagnostic method, this method has a sensitivity,
speciﬁcity, and accuracy equal to 1 [95% CI (0.9415; 1.0000)]. The
same results are obtained if the new diagnostic method is deﬁned
as the simultaneous two-fold increase in TNF-a, IL-6, and CRP
values compared to normal values.
Summaries of serum oxidative stress values assessed according
to the required criteria (presented in the “Materials and methods”
section) and investigated as dichotomic variables by groups are
presented in Table 6.
Systematically, the women from the PE group had lower than
normal values for two oxidative stress markers: hydrogen donor
capacity (<40%) and nitrite and nitrate (<13 mmol/L). If the
following criteria were simultaneously considered: lipid peroxides
>1.9 nmol/mL, carbonylated proteins >1.225 mmol/L, hydrogen
donor capacity <38%, serum nitrite and nitrate <12 mmol/L, all
women from the PE group met the above mentioned criteria, whileTable 2
Distribution of women according to the investigated criteria expressed as number
and percentage.
Parameter (criterion) Group
Preeclampsia
(n ¼ 80)
No. (%)
Normal pregnancy
(n ¼ 78)
No. (%)
Control
(n ¼ 72)
No. (%)
Leukocytosis (>10,000) 54 (68) 39 (50) 1 (1)
Neutrophils (>7000) 61 (76) 51 (65) 2 (3)
TNF-a (>6.6) 80 (100) 9 (12) 8 (11)
TNF-a (>13.2; 2  6.6) 80 (100) 0 (0) 3 (4)
TNF-a (>19.8; 3  6.6) 80 (100) 0 (0) 0 (0)
IL-6 (>1.2) 80 (100) 66 (85) 27 (38)
IL-6 (>2.4; 2  1.2) 80 (100) 13 (17) 3 (4)
IL-6 (>3.6; 3  1.2) 80 (100) 3 (4) 0 (0)
CRP (>1000) 80 (100) 78 (100) 29 (40)
CRP (>2000; 2  1000) 80 (100) 76 (97) 2 (3)
CRP (>3000; 3  1000) 75 (94) 64 (82) 0 (0)
CRP ¼ C-reactive protein; IL-6 ¼ interleukin-6; TNF-a ¼ tumor necrosis factor-a.none of the women from either the NP group or the C group met
them. A sensitivity of 1 [95% CI (09429; 1.0000)], a speciﬁcity of 1
[95% CI (0.9415; 1.0000)], a predictive positive value of 1 [95% CI
(0.9429; 1.0000)], and a predictive negative value of 1 [95% CI
(0.9415; 1.0000)] were obtained in this context.
Fetal parameters and the route of delivery in the PE group versus the
NP group
In the PE group, there were 61 births by cesarean section, and in
the NP group, 41 births by cesarean section, which leads to a sta-
tistical difference in the type of delivery between the two groups (Z
statistics ¼ 3.2083, p ¼ 0.0013). The results of descriptive and
inferential statistics performed for the differences between the NP
and PE groups regarding gestational age, birth weight, and Apgar
score are shown in Table 7.
The analysis of birth weight (expressed as underweight, normal
weight, and overweight) in the NP and PE groups identiﬁed a
signiﬁcantly higher number of underweight newborns in the PE
group (Z statistics ¼ 2.4109, p ¼ 0.0159).
Fetal parameters and the route of delivery in the PE group
In the PE group, 43 patients had the moderate form and 37
patients had the severe form of PE. The Apgar score was not
signiﬁcantly different in the case of newborns of patients with se-
vere PE, compared to the patients with moderate PE (Z
statistics ¼ 1.456, p ¼ 0.145). Signiﬁcant differences were ob-
tained when both gestational age (Z statistics ¼ 3.524,
p ¼ 4.25$  104) and birth weight (Z statistics ¼ 3.580,
p ¼ 3.44$  104) were compared between the subgroups with
moderate and severe PE. The median of gestational age in the
subgroup with moderate PE was 39 weeks (25% quartile ¼ 38
weeks, 75% quartile ¼ 40 weeks), while the median of gestational
age in the subgroup with severe PE was 37 weeks (25%
quartile ¼ 35 weeks, 75% quartile ¼ 38 weeks). The median of birth
weight in the subgroup with moderate PE was 3200 g (25%
quartile¼ 2800 g, 75% quartile¼ 3600 g), while themedian of birth
weight in the subgroup with severe PE was 2700 g (25%
quartile ¼ 1950 g, 75% quartile ¼ 3000 g). The results of descriptive
and inferential statistics of birth weight classes, type of delivery,
and Apgar score according to PE subgroup are presented in Table 8.
The distribution of increased inﬂammatory parameters accord-
ing to the severity of PE by birth weight classes is presented in
Table 9.
There were no signiﬁcant differences in the investigated serum
inﬂammatory parameters when the proportion of overweight
newborns from the subgroup with moderate preeclampsia was
compared to the subgroup with severe preeclampsia (Z statis-
tics < 0.4675, p > 0.6). According to the distribution of underweight
and normal weight in the groups with moderate and severe pre-
eclampsia, signiﬁcant differences in the inﬂammatory parameters
were identiﬁed (p < 0.05).
Discussion
Preeclampsia is a systemic syndrome characterized by an in-
ﬂammatory and antiangiogenetic status. The pathogenesis of PE
involves a trophoblastic invasion deﬁcit that is responsible for the
alteration of uterine ﬂow and the development of placental
oxidative stress. All processes involved in inﬂammation, endothe-
lial dysfunction, and oxidative stress are closely correlated and act
synergistically. The theories of “excessive inﬂammation” and
“angiogenic imbalance” are considered causes of PE [4,11].
Table 3
Two-proportion Z test and associated p values.
Parameter (criteria) Z statistics (p)
PE vs. NP PE vs. C NP vs. C
Leukocytosis (>10,000) 2.34 (p ¼ 0.0194) 12.53 (p < 0.0001) 8.48 (p < 0.0001)
Neutrophils (>7000) 1.53 (p ¼ 0.127) 14.09 (p < 0.0001) 10.76 (p < 0.0001)
TNF-a (>6.6) 23.92 (p < 0.0001) 24.14 (p < 0.0001) 0.19 (p ¼ 0.8478)
TNF-a (>13.2; 2  6.6) 12.57 (p < 0.0001) 11.87 (p < 0.0001) 1.97 (p ¼ 0.0756)
TNF-a (>19.8; 3  6.6) >100 (p < 0.0001) >100 (p < 0.0001) 0.00 (p ¼ 1.0000)
IL-6 (>1.2) 3.71 (p ¼ 0.0002) 10.34 (p < 0.0001) 6.71 (p < 0.0001)
IL-6 (>2.4; 2  1.2) 10.61 (p < 0.0001) 11.87 (p < 0.0001) 2.57 (p ¼ 0.0103)
IL-6 (>3.6; 3  1.2) 43.27 (p < 0.0001) >100 (p < 0.0001) 1.80 (p ¼ 0.0725)
CRP (>1000) 0.00 (p ¼ 1.0000) 10.39 (p < 0.0001) 10.39 (p < 0.0001)
CRP (>2000; 2  1000) 1.56 (p ¼ 0.1186) 11.98 (p < 0.0001) 11.51 (p < 0.0001)
CRP (>3000; 3  1000) 2.35 (p ¼ 0.0185) 35.40 (p < 0.0001) 18.85 (p < 0.0001)
C ¼ control group; CRP ¼ C-reactive protein; IL-6 ¼ interleukin-6; NP ¼ normal pregnancy group; PE ¼ preeclampsia group; TNF-a ¼ tumor necrosis factor-a.
Table 4
Summary of serum inﬂammatory parameters in the groups and results of the comparisons.
Parameter Statistics PE group NP group C group Z statisticsa (p) PE vs. NP Z statisticsa (p) PE vs. C Z statisticsa (p value) NP vs. C
Leukocytes Median 10,900 10,000 6550 1.538
(0.124)
9.913
(<0.0001)
9.139
(<0.0001)25% quartile 9600 8945 5525
75% quartile 11,975 11,875 7550
Neutrophils Median 8200 7700 4050 1.673
(0.094)
9.871
(<0.0001)
9.105
(<0.0001)25% quartile 7100 6560 3025
75% quartile 9575 8975 5075
TNF-a Median 30.760 2.670 1.775 10.854
(<0.0001)
10.632
(<0.0001)
2.184
(0.0290)25% quartile 28.633 1.513 0.888
75% quartile 32.000 5.513 4.548
IL-6 Median 7.570 1.815 1.010 10.844
(<0.0001)
10.628
(<0.0001)
6.644
(<0.0001)25% quartile 6.655 1.520 0.633
75% quartile 8.915 2.043 1.498
CRP Median 4034 4776 847.85 2.142
(0.032)
10.630
(<0.0001)
10.421
(<0.0001)25% quartile 3789 3241 571.13
75% quartile 4596 5468 1157.3
C ¼ control group; CRP ¼ C-reactive protein; IL-6 ¼ interleukin-6; NP ¼ normal pregnancy group; PE ¼ preeclampsia group; TNF-a ¼ tumor necrosis factor-a.
a Z statistics associated with the ManneWhitney test.
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oxidative stress markers in healthy nonpregnant patients, patients
with a normal pregnancy evolution, and pregnant women with PE
were investigated. Statistically signiﬁcantly increased values of
leukocytes and neutrophils in the PE group and the NP group,
respectively, compared to the C group have been found, although
these parameters cannot be considered speciﬁc for either the NP or
the PE group. The identiﬁed increase in the number of circulatingTable 5
Summary of serum inﬂammatory parameters by preeclampsia severity classes and
their comparisons.
Parameter Statistics Moderate
preeclampsia
Severe
preeclampsia
Z statistics (p)
Leukocytes Median 10,800 11,100 0.405 (0.685)
25% quartile 9400 9700
75% quartile 12,300 11,800
Neutrophils Median 8200 8200 0.565 (0.572)
25% quartile 6900 7300
75% quartile 9800 9200
TNF-a Median 30.28 31.30 0.561 (0.575)
25% quartile 28.24 28.76
75% quartile 32.41 32.00
IL-6 Median 7.41 7.90 1.761 (0.078)
25% quartile 6.41 6.91
75% quartile 8.78 9.95
CRP Median 4015 4333 0.097 (0.923)
25% quartile 3790 3730
75% quartile 4599 4731
CRP ¼ C-reactive protein; IL-6 ¼ interleukin-6; TNF-a ¼ tumor necrosis factor-a.leukocytes is most probably due to the high cortisol levels in
pregnancy, which stimulate their mobilization at the level of mar-
ginal pools [12]. Other studies have evidenced an increase in
neutrophil activation in PE compared to NP, both in the placental
territory and systemic circulation [13]. The same authors have
demonstrated that in PE there is a modulation of neutrophil func-
tion towards a higher production of superoxide compared to nitric
oxide (NO), which results in endothelial damage and dysfunction
[14]. Ozkaya et al [15] have found that DBP levels > 120 mmHg and
leukocyte count > 16,000/mL are independent predictors of the
eclamptic crisis.
In our study, the two- and three-fold increase in serum IL-6
levels is speciﬁc for the PE group (Table 3). Longitudinal studiesTable 6
Distribution of serum oxidative stress markers expressed as number and percentage
(round brackets).
Parameter (criterion) Preeclampsia
(%)
Normal
pregnancy (%)
Control
group (%)
Lipid peroxides
(>1.9 nmol/mL)
80 (100) 61 (78) 6 (8)
Carbonylated proteins
(>1.225 nmol/mg)
80 (100) 78 (100) 51 (71)
Ceruloplasmin
(>32 mg/100 mL)
0 (0) 78 (100) 33 (46)
Hydrogen donor
capacity (>40%)
0 (0) 78 (100) 27 (38)
Serum nitrite and
nitrate (>13 mmol/L)
0 (0) 78 (100) 7 (10)
Table 7
Descriptive and inferential statistics results: gestational age, birth weight, and Apgar
score.
Preeclampsia
(n ¼ 80)
Normal
pregnancy
(n ¼ 78)
Z statistics
(p)
Gestational
age (weeks)
Median 38 39 3.411 (0.001)
Minimum 29 32
Maximum 41 42
25% Quartile 36 38
75% Quartile 39 39
Birth
weight (g)
Median 3000 3300 3.396 (0.001)
Minimum 990 1600
Maximum 4400 4800
25% Quartile 2425 2975
75% Quartile 3475 3600
Apgar score Median 9 9.50 2.544 (0.011)
Minimum 0 0
Maximum 10 10
25% Quartile 8 9
75% Quartile 10 10
Table 8
Descriptive and inferential statistics: moderate vs. severe preeclampsia.
Preeclampsia Z statistics (p)
Moderate (n ¼ 43)
No. (%)
Severe (n ¼ 37)
No. (%)
Birth weight class
Underweight 6 (14.0) 15 (40.5) 2.7941 (0.0052)
Normal weight 35 (81.4) 21 (56.8) 2.4414 (0.0146)
Overweight 2 (4.7) 1 (2.7) 0.4779 (0.6327)
Delivery
Vaginal 11 (25.6) 8 (21.6) 0.4215 (0.6734)
Cesarean 32 (74.4) 29 (78.4) 0.4215 (0.6734)
Apgar
0 1 (2.3) 0 (0.0) 1.0061 (0.3144)
2 0 (0.0) 1 (2.7) 1.0133 (0.3109)
3 0 (0.0) 0 (0.0) 0.0000 (>0.9999)
4 1 (4.3) 1 (2.7) 0.3919 (0.6951)
5 0 (0.0) 0 (0.0) 0.0000 (>0.9999)
6 1 (4.3) 2 (5.4) 0.2275 (0.8200)
7 3 (7.0) 3 (8.1) 0.1853 (0.8530)
8 4 (9.3) 4 (10.8) 1.7328 (0.0831)
9 16 (37.2) 18 (48.6) 1.0328 (0.3017)
10 17 (39.5) 8 (21.6) 1.7781 (0.0754)
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the ﬁrst trimester of pregnancy, an increase that progresses with
the pregnancy evolution [16]. In PE, signiﬁcantly increased IL-6
values are found compared to NP [17e20]. IL-6 is a multifunc-
tional cytokine that regulates the immune response and acute
phase reactions and may play a central role in host defense
mechanisms [1]. It has been demonstrated that the capacity of IL-6Table 9
Severity of preeclampsia and increased inﬂammatory parameters.
Parameter Moderate preeclampsia (n ¼ 43)
Underweight No. (%) Normal weight No. (%) Overweight
Leukocytosis
(>10000/mL)
2 (4.65) 25 (58.14) 1 (
Neutrophils
(>7000/mL)
2 (4.65) 28 (65.12) 1 (
TNF-a (>6.6 pg/mL) 6 (13.95) 35 (81.40) 2 (
TNF-a (>19.8 pg/mL) 6 (13.95) 35 (81.40) 2 (
IL-6 (>1.2 pg/mL) 5 (11.63) 24 (55.81) 2 (
CRP (>1000 pg/mL) 6 (13.95) 35 (81.40) 2 (
CRP (>3000 pg/mL) 6 (13.95) 32 (74.42) 2 (
CRP ¼ C-reactive protein; IL-6 ¼ interleukin-6; TNF-a ¼ tumor necrosis factor-a.to interfere with contraction and relaxation mechanisms in sys-
temic vessels in pregnancy plays a role in the modeling of vascular
resistance and, implicitly, of blood pressure [21]. Possible sources of
IL-6 in PE might include activated leukocytes and monocytes and
maternal endothelial cells after exposure to various stimuli such as
TNF-a [22,23].
The results of our study support the hypothesis that a three-fold
increase in TNF-a values compared to normal values is speciﬁc for
the PE group (Table 2). Studies have evidenced a signiﬁcant rise of
serum TNF-a value in the last trimester of pregnancy compared to
nonpregnancy status [16,24]. Many authors believe that circulating
TNF-a and IL-6 levels are increased in patients with PE compared to
normotensive nonpregnant patients [25e27]. However, other au-
thors have failed to identify a correlation between maternal serum
IL-6 and TNF-a levels and preeclampsia [28]. Many studies in the
literature have evaluated circulating TNF-a level in PE as a bioac-
tive or immunoreactive agent, with different results depending on
the chosen study method [29,30]. The results obtained are
extremely controversial, increased, unchanged, or even insigniﬁ-
cantly decreased circulating TNF-a levels being reported in preg-
nant women with PE, compared to NP in the last trimester
[26,29,30]. Cackovic et al [31] support the hypothesis that serum
TNF-a levels are signiﬁcantly reduced in patients with PE and
suggest a low clearance and an altered renal excretion of TNF-a,
which might cause PE. One of the most studied hypotheses is the
excessive production and release of TNF-a from the preeclamptic
placenta as a consequence of hypoxia [32]. Activated leukocytes
and neutrophils are another TNF-a source in normal and patho-
logical pregnancies [33,34]. An increased TNF-a level might be the
cause of endothelial dysfunction both directly and indirectly [1,35].
The increase in the production of proinﬂammatory cytokines has
been associated with endothelial dysfunction, increased cell
apoptosis, the diminution of the angiogenetic process, and renal
abnormalities, all of which are relevant in the pathophysiology of
PE [1,36].
The results of our study show that serum CRP levels >1000 ng/
mL are speciﬁc for pregnancy, without any difference being found
between the NP and PE groups (see Table 2). Serum CRP values
>3000 ng/mL proved to be speciﬁc for the PE group compared to
the NP group (Table 3). CRP is a marker of systemic low-grade
inﬂammation, an acute phase reactant produced in the liver as a
response to stress, tissue injury, and the most sensitive glycopro-
tein marker of overall inﬂammatory activity in the body [37,38].
Both in vivo and in vitro studies have demonstrated that human
placental tissue can produce and release CRP, mainly in the
maternal circulation [39]. In NP, increased CRP levels are the result
of the presence of a variety of stimuli that appear at different stages
of pregnancy: implantation and the production of IL-6 by activated
decidual monocytes/macrophages, apoptotic and necrotic pro-
cesses associated with placental aging, as well as the progressiveSevere preeclampsia (n ¼ 37)
No. (%) Underweight No. (%) Normal weight No. (%) Overweight No. (%)
2.33) 12 (32.43) 13 (35.14) 1 (2.70)
2.33) 14 (37.84) 15 (40.54) 1 (2.70)
4.65) 15 (40.54) 21 (56.76) 1 (2.70)
4.65) 15 (40.54) 21 (56.76) 1 (2.70)
4.65) 12 (32.43) 18 (48.65) 1 (2.70)
4.65) 15 (40.54) 21 (56.76) 1 (2.70)
4.65) 14 (37.84) 20 (54.05) 1 (2.70)
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nancy [12,40,41]. Several studies have been conducted to elucidate
a relationship between PE and serum CRP levels [42]. Some of these
report increased CRP levels in preeclamptic patients compared to
normotensive pregnant women [42,43]. There are also studies that
have evidenced statistically insigniﬁcant differences between
serum CRP values in patients with PE compared to NP in the last
trimester of pregnancy [44].
The results of our study substantiate an increase in the bio-
markers of reactive oxygen species (ROS), which is partially coun-
tered by the enhancement of antioxidant mechanisms in NP. This
balance is changed in the PE group, in which we found an increase
in ROS production and a decrease in antioxidant values. Thus, the
implication of oxidative stress in the development of systemic in-
ﬂammatory response in PE is supported. Normal pregnant women
exhibit an increase in lipid peroxidation and oxidative stress
compared to nonpregnant women [45,46]. Oxidative stress plays a
role in both the normal development of the placenta and the
pathophysiology of complications such as preeclampsia and intra-
uterine growth restriction (IUGR) [47,48]. PE is characterized by
increased oxidative stress and decreased antioxidants [46,49e51].
The decreased antioxidant activity supports the hypothesis that
lipid peroxidation is an important causative factor in the patho-
genesis of PE [52]. The measurement of single components may not
be a reliable indicator of oxidative stress under physiological and
pathological conditions [53]. Studies have evidenced an increase in
lipid peroxidation in PE [54]. The main action mechanisms of ROS
can be synthesized as follows: activation of redox sensitive tran-
scription factors; activation of protein kinases; opening of iron
channels; lipid peroxidation; protein modiﬁcation; and DNA
oxidation [55,56].
The analysis of our obtained results shows that none of these
inﬂammatory parameters can be used for the evaluation of the
severity of preeclampsia. In this sense, the study performed by Can
et al [57] supports the fact that in severe PE serum CRP levels are
signiﬁcantly increased compared to moderate preeclampsia.
Nunez-Gonzales et al [58] report highly signiﬁcant positive corre-
lations between serum TNF-a concentration and systolic/diastolic
BP values. Moreover, Vitoratos et al [1] suggest a possible associa-
tion betweenTNF-a and the severity of PE. There are studies ﬁnding
no difference regarding the relationship between antioxidant sta-
tus, lipid peroxidation, protein oxidation products, and the severity
of PE [59], but some authors report a signiﬁcant correlation be-
tween diastolic blood pressure values in PE and the increase in the
serum lipoperoxide level [60].
From our result, we can positively state that by associating at
least two of the studied inﬂammatory markers, IL-6 and TNFa, both
of them with a two-fold increase or more compared to normal
values, could be used as a diagnostic method.
Regarding fetal status at birth, our study showed the following
aspects: gestational age, birth weight, and Apgar score were
signiﬁcantly lower in the PE group compared to the NP group
(Table 8). We also found a signiﬁcantly higher number of under-
weight neonates born from pregnancies with severe PE compared
to newborns from pregnancies with moderate PE (p < 0.05). The
results of other studies show a positive correlation between
maternal serum CRP values and the duration of pregnancy in the
case of pregnant women with a normal evolution [61]. Other au-
thors have obtained a negative correlation between maternal CRP
values and fetal weight, as well as between CRP values and gesta-
tional age in the group of pregnant women with PE [42,62]. Some
authors suggest an association between the intensity of maternal
oxidative stress and low fetal birth weight [63,64].
The value of our study resides in evaluation of prognostic
markers of inﬂammatory syndrome in pregnant women withpreeclampsia compared to normal pregnancy. In conclusion, in PE
there is a marked systemic inﬂammatory response compared to NP,
which can inﬂuence fetal status at birth. None of the investigated
inﬂammatory parameters can be used for evaluating the severity of
PE.
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